Soluble guanylyl cyclase (sGC, EC 4.6.1.2) is a key enzyme in the regulation of vascular tone. In view of the therapeutic interest of the NO/cGMP pathway, drugs were developed that either increase the NO sensitivity of the enzyme or activate heme-free apo-sGC. However, modulation of sGC activity by endogenous agents is poorly understood. In the present study we show that the maximal activity of NO-stimulated purified sGC is significantly increased by cytosolic preparations of porcine coronary arteries. Purification of the active principle by several chromatographic steps resulted in a protein mixture consisting of 100, 70, and 40 kDa bands on SDS polyacrylamide gel electrophoresis. The respective proteins were identified by LC-MS/MS as gelsolin, annexin A6, and actin, respectively. Further purification resulted in loss of activity, indicating an interaction of sGC with a protein complex rather than a single protein. The partially purified preparation had no effect on basal sGC activity or enzyme activation by the heme mimetic BAY 60-2770, suggesting a specific effect on the conformation of the NO-bound heterodimeric holoenzyme. Since the three proteins identified are all related to contractile elements of smooth muscle, our data suggest that regulation of vascular tone involves a modulatory interaction of sGC with the cytoskeleton.
Introduction
The signaling molecule nitric oxide (NO) plays an essential role in vessel homeostasis by initiating vasodilation [1] [2] [3] . After biosynthesis in endothelial cells, NO diffuses into the subjacent smooth muscle layer to reach its target enzyme, soluble guanylyl cyclase (sGC, EC 4.6.1.2). Upon binding of NO to the prosthetic heme group of sGC, the enzyme gets activated and catalyzes the formation of the second messenger cGMP. Elevated levels of cGMP eventually lead to relaxation of vascular smooth muscle [4] . As sGC plays a crucial role in vasodilation, there is great interest in the pharmacological modulation of this enzyme in a variety of cardiovascular diseases [5] . Low molecular weight compounds that increase sGC activity in tissues have been described as stimulators and activators of the enzyme. While stimulators sensitize holo-sGC towards NO, activators mimic formation of the active nitrosylheme complex by binding to the heme-free enzyme [6] . The first described stimulator of sGC was YC-1 [7, 8] , which stabilizes the NO-heme complex. High throughput screening and pharmacokinetic optimization resulted in the development of the orally usable drug riociguat (BAY 63-2521) [9] . The two most frequently studied activators of sGC are cinaciguat (BAY 58-2667) and compound BAY 60-2770. Activators are of great interest in the therapy of cardiovascular diseases associated with oxidative stress in the vasculature [6, [10] [11] [12] . Besides these low molecular weight compounds some proteins are known to regulate sGC activity by direct protein-protein interaction. Members of the heat shock protein (Hsp) family are of particular interest. Hsp70 was claimed to act as endogenous activator of sGC, but addition of exogenous Hsp70 to purified sGC had no effect [13] , so the role of Hsp70 is still unclear. In contrast, there is a large body of evidence indicating that Hsp90 functions as chaperone in the maturation of the NO-responsive active sGC heterodimer (for review, see Ref. [14] ). Recently, we reported that heme-free cytosolic preparations of porcine coronary arteries (PCA) increase the maximal activity of NO-stimulated sGC [15] . Preliminary experiments suggested that this effect is mediated by a protein which will be further referred to as sGC-activating factor (sGC-AF). In the present study we describe the partial purification and identification of this protein.
Materials & methods

Chemicals
Bovine lung sGC was purified as described [16] . 2,2-Diethyl-1-nitroso-oxyhydrazine (DEA/NO), S-nitrosoglutathione (GSNO), and BAY 41-2272 were from Enzo Life Sciences (Lausen, Switzerland) obtained via Eubio (Vienna, Austria). Cinaciguat (BAY 58-2667) was obtained from Axon Medchem (Groningen, Netherlands). [α- 32 P]GTP (800 Ci/ mmol; NEN Radiochemicals) was obtained from PerkinElmer Life and Analytical Sciences (Vienna, Austria). Monoclonal mouse antibodies against annexin A6 (sc-271859) and heat shock protein 70 (sc-66048) were obtained from Santa Cruz (Heidelberg, Germany). All other chemicals were obtained from Sigma-Aldrich (Vienna, Austria).
Preparation of cytosols from PCA
Porcine hearts were obtained from a local slaughterhouse and transported to the laboratory as quickly as possible. Coronary arteries (i.e. arteria coronaria dextra, arteria coronaria sinistra, ramus circumflexus, and ramus interventricularis anterior) of 10 hearts were explanted for one preparation. Surrounding fat and connective tissue were dissected and the vessels were transferred to ice-cold PBS. After cutting them open longitudinally to expose the luminal side, the vessel strips were washed extensively in ice-cold PBS. All following steps were performed in a cold room at 4°C. The washed tissue pieces were blotted dry using filter paper, snap frozen in liquid nitrogen, and ground to a fine powder using pre-chilled mortar and pestle. The tissue powder was combined with a total volume of 50 ml homogenization buffer (125 mM KCl, 10 mM Tris/HCl, pH 7.4, 5 mM EGTA/K + , 2 mM MgCl 2 ). The mixture was then homogenized with an Ultraturrax tissue blender by three consecutive bursts (20 s each with 30 s resting time on ice in between). The crude homogenate was passed through a nylon mesh to remove tissue debris. To obtain cytosolic preparations, particulate material was pelleted by ultracentrifugation (100,000×g for 90 min at 4°C). The supernatants were passed through filter paper and concentrated using a stirred ultrafiltration cell (Millipore) equipped with a regenerated cellulose membrane (10 kDa molecular weight cut-off). The concentrated cytosols (approximately 15 ml) were stored at −80°C in 5 ml aliquots.
Determination of protein concentration
Protein concentration was determined with the Pierce BCA Protein Assay Kit (Fisher Scientific Austria, Vienna, Austria) according to the protocol supplied by the manufacturer, using BSA as standard.
Fractionation of PCA cytosols by ammonium sulfate precipitation
Increasing amounts of ammonium sulfate powder were added in 10% saturation steps under gentle stirring (calculated using an online ammonium sulfate calculator: www.encorbio.com/protocols/AM-SO4. htm). After equilibrating for 60 min at 0°C under constant stirring the precipitates were collected by centrifugation for 20 min at 20,000×g. Pellets were washed once with the respective ammonium sulfate solutions and then resuspended in 50 mM TEA/HCl (pH 7.4). Residual ammonium sulfate was removed by passing over Amicon ultracentrifugal filters (10 kDa molecular weight cut-off, Merck-Millipore) four times with restock of buffer after every run.
Fractionation of PCA cytosols by FPLC
Fractionation of cytosolic preparations by FPLC was performed using an Äkta purifier system (GE-Healthcare) equipped with two pumps for generating gradients, a three channel UV monitor, pH and conductivity sensors, and a fraction collector. The whole equipment was located in a cold room (4°C). The three chromatographic methods used were hydrophobic interaction, ion exchange, and size exclusion (gel filtration), and will be described in detail in the following paragraphs.
Hydrophobic interaction chromatography (HIC)
PCA cytosols were quickly thawed in a water bath (37°C) and immediately transferred to an ice bath. To prepare samples for HIC solid NaCl was slowly added while stirring to yield a final concentration of 4 M (234 mg/ml). Note: Freezing the cytosolic preparations resulted in precipitation of some of its content. Most of this precipitate re-dissolved after addition of NaCl. Any insoluble material was removed by centrifugation (50,000×g, 20 min, 4°C). 5 ml of the resulting supernatant was passed through a syringe filter (0.2 µm pore size) and subjected to a 1 ml HiTrap Phenyl Sepharose HP column (GE-Healthcare) that was attached to the Äkta purifier system and had been equilibrated in HIC binding buffer (50 mM TEA/HCl, pH 7.4, 4 M NaCl). After washing out unbound material with 5-10 ml of binding buffer, proteins were eluted with a decreasing linear salt gradient from 4 M to 0 M NaCl (0.5 ml/ min, 20 ml total) and collected in 0.5 ml fractions. NaCl was removed using PD-10 columns containing Sephadex G-25 (GE-Healthcare) and the fractions were tested for sGC-AF activity.
Ion exchange chromatography (IEX)
Thawed PCA cytosol that had been clarified by centrifugation (50,000×g, 20 min, 4°C), or pooled and desalted fractions from HIC were passed through a syringe filter (0.2 µm pore size) and subjected to a 1 ml Q Sepharose FF anion exchange column (GE-Healthcare) that had been equilibrated in IEX binding buffer (20 mM TEA/HCl, pH 8.0) using the Äkta purifier system. After washing out unbound material with 5-10 ml of binding buffer, proteins were eluted with an increasing linear salt gradient from 0 M to 0.6 M NaCl (0.5 ml/min, 30 ml total) and collected in 0.5 ml fractions. NaCl was removed using PD-10 columns containing Sephadex G-25 (GE-Healthcare) and the fractions were tested for sGC-AF activity.
Size exclusion chromatography (SEC)
Pools of partially purified sGC-AF (derived from HIC with subsequent IEX as described above) were concentrated using centrifugal filter units (Merck-Millipore, 10 kDa cut-off). The resulting concentrate (∼250 µl) was applied to a gel filtration column (Superdex 200 increase 10/300 GL, GE-Healthcare) that had been equilibrated in SEC buffer (100 mM TEA/HCl, pH 7.4) using the Äkta purifier system. Samples of PCA cytosols (0.5 ml) were applied without further concentrating. Proteins were separated at a flow rate of 0.5 ml/min and collected in 0.5 ml fractions.
sGC activity assay
The activity of sGC was determined as described previously [17] . Briefly, purified bovine lung sGC (50 ng) was incubated at 37°C for 10 min in a final volume of 0.1 ml in the absence or presence of PCA cytosols or sGC-AF preparations as indicated in the figure legends. Assay mixtures contained 50 mM TEA/HCl, 0.5 mM [α-
32 P]GTP (∼200,000 cpm), 3 mM MgCl 2 , and 1 mM cGMP. In addition, the mixture contained 1 mM IBMX, 1 mM EGTA, 2 mM DTT, 0.1 mM DTPA, 5 mM CP, 152 mU/ml CK, and 1,000 U/ml SOD. Unless stated otherwise, reactions were started by addition of DEA/NO (10 µM) and terminated by adding 0.45 ml zinc acetate (120 mM) and 0.45 ml sodium bicarbonate (120 mM). After centrifugation (20, 6 ]) and purified by anion exchange chromatography using DEAE Sephadex (GE Healthcare) as described previously [18] . In short, sGC (2 µg) was incubated at ambient temperature in a final volume of 0.1 ml of binding buffer (50 mM TEA/HCl, pH 7.4) containing either sodium dithionite (0.1 mM) for reduction or ferricyanide (5 µM) for oxidation. After 1 min the preparation was mixed with 50 µl of a 50% slurry of the ion exchange resin in binding buffer. This mixture was supplied to the upper half of a 200 µl pipette tip with a polyethylene filter (SafeSeal Tips Professional, Biozym) to generate a micro-column.
The column was washed twice with 100 µl of binding buffer. The bound enzyme was eluted with 100 µl of binding buffer containing 250 mM NaCl and used in activity assays as described above.
Electrophoresis and Western blotting
Samples were mixed with an equal volume of Lämmli sample buffer (2×) and denatured for 5 min at 95°C. The denatured samples were separated by SDS-PAGE on single percentage or gradient gels (10% and 4-20%, respectively) and then electrophoretically transferred onto nitrocellulose membranes (0.45 µm). After blocking with 5% nonfat dry milk ((w/v) in Tris-buffered saline, containing 0.05% Tween 20 (v/v)) for 1 h, membranes were incubated for 1 h at ambient temperature with the corresponding primary antibodies. After incubation of membranes with horseradish peroxidase-conjugated anti-mouse IgG (1 h, ambient temperature), immunoreactive bands were visualized by chemiluminescence using ECL Prime Western Blot Detection Reagent (GE Healthcare, purchased via VWR, Vienna, Austria). Images were taken with a Fusion SL imaging system (Vilber Lourmat) and analyzed with the Fusion Capt software (Vilber Lourmat).
In-gel protein digestion
Protein bands from SDS-PAGE were excised from the gel, washed for 10 min each with 200 µl 50 mM NH 4 HCO 3 and NH 4 HCO 3 :acetonitrile 1:1, followed by dehydration with acetonitrile (HPLC grade, VWR, Radnor, USA). Each sample was then subjected to reduction with 100 µl of a 50 mM NH 4 HCO 3 solution, containing 10 mM DTT at 54°C for 30 min and to alkylation with 150 µl of a 50 mM NH 4 HCO 3 solution, containing 50 mM iodoacetamide for 20 min at ambient temperature in the dark. The gel slices were then washed again with 50 mM NH 4 HCO 3 , followed by washing with acetonitrile and then dried in a vacuum centrifuge. For in-gel digestion, the gel slices were rehydrated in 15 µl of a trypsin solution (5 ng/µl; sequencing grade trypsin, Roche, Basel, Switzerland) in 50 mM NH 4 HCO 3 and incubated overnight at 37°C. Peptides were extracted from the gel matrix with 25 µl 50 mM NH 4 HCO 3 and subsequently two times with 25 µl 5% formic acid in an ultrasonic bath. All supernatants were combined and analyzed by nano-LC-MS/MS.
Nano-LC-MS/MS
All nano-LC separations were performed on an UltiMate 3000 HPLC system (Thermo Fisher Scientific, Waltham, USA). The flow rate of the nano-HPLC system was set at 250 nl/min and the UV detector was operated at λ = 214 nm. The loading pump was operated at 20 µl/min. The trap column dimensions were 300 µm id × 5 mm length, packed with PepMap C18. After a sample loading time of 10 min, the trap column was switched in line with the nanocolumn. The sample was eluted in back flush mode. The mobile phases were: (A) 99.9% water (HPLC grade, VWR) and 0.1% formic acid; and (B) 80% acetonitrile (HPLC grade, VWR) and 0.08% formic acid. The mobile phase for the loading pump was water with 0.05% TFA. The HPLC gradient for separation was 4% B for 10 min, 4-40% B in 90 min, and 40-90% B in 5 min, 90% B for 5 min, 4% B for 20 min. For separation an Acclaim PepMap RSLC column (C18, 75 µm × 150 mm, 2 µm, 100 Å) was used. Eluted peptides were ionized via stainless steel emitters using the Nanospray Flex™ ion source (Thermo Fisher Scientific) and directly introduced into an ion trap mass spectrometer (LTQ XL, Thermo Fisher Scientific). The following electrospray ionization parameters were used: spray voltage, 1.7 kV; capillary temperature, 200°C; capillary voltage, 30 V. The collision energy was set automatically depending on the mass of the parent ion. The data were collected in the centroid mode using one MS experiment followed by five MS/MS experiments of the most intensive ions (intensity at least 5·10 3 ). Dynamic exclusion was used for data acquisition with exclusion duration of 2 min and an exclusion mass width of ± 1.5 Da.
MS data analysis
For peptide identification, RAW-files were converted into MGF-files using ProteoWizard [19] and analyzed with the MASCOT search engine (Matrix Science, London, UK). All MS/MS spectra were searched against the SwissProt protein sequence database (www.uniprot.org). Following search parameters were used: carbamidomethylation on cysteine was set as a fixed modification; oxidation on methionine was set as a variable modification; trypsin was set as enzyme; the precursor mass tolerance was set to 3 Da; the fragment mass tolerance was set to 0.8 Da; the maximal number of missed cleavages was set to 2. The results were filtered to peptide scores ≥30 and to 1% false discovery rate using Mascot.
Statistical analysis
Data are presented as mean values ± SEM of n experiments (as indicated in the figure legends). Student's paired t-test and ANOVA with Bonferroni post hoc test were performed using Kaleidagraph software (version 4.5.3 by Synergy Software). Significance was assumed at p < 0.05.
Results
Effect of PCA cytosol on purified sGC
As described previously, the increase of sGC activity by PCA cytosols is masked by significant NO scavenging due to hemoglobin contamination [15] . In the presence of hemoglobin-depleted cytosols maximal sGC activity determined in the presence of 10 µM DEA/NO was increased in a protein-dependent manner (Fig. 1A) . Amounts of 25, 50, and 100 µg of total cytosolic protein increased cGMP formation from 33.1 ± 1.6 µmol·min −1 ·mg −1 to 47.9 ± 0.6, 51.2 ± 2.0, and 54.9 ± 2.2 µmol·min
, respectively. Fig. 1B shows that this effect is not explained by the presence of endogenous sGC in the cytosolic PCA preparations. Since basal sGC activity was not affected by PCA cytosol (not shown), we considered a possible effect on NO release from DEA/NO, but virtually identical results were obtained with GSNO (Fig. 1C) . To ensure maximal sGC activation by NO, all subsequent experiments were performed with 10 µM DEA/NO. However, virtually identical increases in activity were observed with 0.3 µM of the NO donor (data not shown).
Enrichment of sGC-AF by precipitation
In a first attempt to enrich sGC-AF we fractionated PCA cytosols by ammonium sulfate precipitation. Fractions from 30% to 100% saturation (with 10% increments) were tested for sGC-AF activity. As shown in Fig. 2A there was a clear accumulation of activity that reached a maximum at 60%-70% saturation. In the presence of the 70% fraction maximal sGC activity was increased from 37.2 ± 7.9 to 68.2 ± 10.2 µmol·min . Together with our observation that the effect of sGC-AF was independent of incubation time (see Fig. 5A below), these findings exclude unspecific enzyme stabilization as underlying mechanism.
Enrichment of sGC-AF by column chromatography
In order to isolate sGC-AF we used an Äkta FPLC system and employed three standard chromatographic methods. At first we applied hydrophobic interaction chromatography (HIC) to enrich sGC-AF from cytosols. Best binding of the factor to the column was obtained with Phenyl Sepharose and TEA/HCl buffer (50 mM, pH 7.4) containing 4 M sodium chloride. When eluting the bound proteins with a linear salt gradient from 4 to 0 M NaCl there was a clear accumulation of sGC-AF. In Fig. 3A a representative chromatogram of a separation run is shown. The bold line indicates the total protein content (absorbance at 280 nm) during the gradient, while the decrease in salt is indicated by the measured conductivity of the buffer (dashed line). Fig. 3D shows the Fig. 1 . sGC-AF activity in PCA cytosol. A) Purified sGC (50 ng) was co-incubated with 25, 50, and 100 µg of PCA cytosol and stimulated with DEA/NO (10 µM). B) Formation of cGMP by purified sGC (50 ng), PCA cytosol (50 µg), and both combined under stimulation with DEA/NO (10 µM). For better comparability product formation is expressed as nmol cGMP per minute. C) Purified sGC (50 ng) was incubated in the absence (control) or presence of PCA cytosol (50 µg) and cGMP formation was stimulated with DEA/NO (10 µM) or GSNO (10 µM). Formation of cGMP was determined as described under Materials and Methods. Data represent mean values of 3 individual experiments ± SEM. The asterisk indicates p < 0.05 in paired Student's t-test. representative chromatogram of such an IEX run is shown in Fig. 3B . The bold line indicates total protein (absorbance at 280 nm) while the dashed line indicates the salt gradient (conductivity of buffer). The effect of the yielded fractions on sGC activity is shown in Fig. 3E . Again, a clear enrichment of sGC-AF activity was observed with a maximum in fraction 11. After HIC and IEX we added a final size exclusion chromatography (gel filtration) step. Fig. 3C shows a representative For clarity the change in sGC activity compared to control is shown. The obtained fractions were subjected to SDS-PAGE and the gels were stained with Coomassie blue R250 (G-I). Fractions obtained from HIC (G) and IEX (H) were analyzed on a 10% gel, and fractions from SEC (I) were analyzed on a 4-20% gradient gel. The gray shading designates the most active fractions, which were pooled and subjected to the next chromatography step. In addition to the individual SEC fractions the pool of the most active fractions was analyzed on the same gel (pool). The outermost lanes contained marker proteins (M) with the indicated apparent molecular weight. Electrophoresis was performed as described under Materials and Methods. Note: the curved appearance of the gel shown in I (indicated by the dotted line) is a result of uneven shrinkage during the staining process caused by the polymer gradient. All shown results are representative for 3 individual experiments.
chromatogram. The proteins subjected to SEC (i.e. sGC-AF pre-purified by HIC and subsequent IEX) basically eluted as a single peak, that shares the elution time with BSA (tested separately under the same conditions). Thus, its molecular weight was estimated to be around 70 kDa (indicated). In Fig. 3F the effects of the corresponding fractions on sGC activity are shown. Clearly, the highest effects correlated with the main protein peak. In panels G, H, and I of Fig. 3 , respectively, SDS-PAGE gels of the fractions obtained by HIC, IEX, and SEC are shown. The gray shading of some fraction numbers indicates the most active fractions of the respective purification step, which were pooled and subjected to the next step. The fractions of HIC and IEX were analyzed on a 10% gel, while the SEC fractions were analyzed on a 4-20% gradient gel. The final preparation of sGC-AF exhibited no detectable sGC activity in the presence of 10 µM DEA/NO, excluding co-purification of the enzyme (data not shown).
Identification of proteins in crude sGC-AF
In order to identify sGC-AF we performed LC-MS/MS analysis with subsequent data base search. Partially purified sGC-AF was subjected to gradient SDS-PAGE (4-20%), which yielded three predominant bands at approximately 40, 70, and 100 kDa (cf. Fig. 3I ). The protein bands were excised, tryptically digested, and subjected to mass spectrometry. The obtained peptide pattern resulted in the protein distributions shown in Table 1 , where the most abundant proteins identified are listed together with their relative amount (based on the corresponding exponentially modified protein abundance index (emPAI) [20] ). The most abundant proteins in the analyzed bands were gelsolin, serum albumin, annexin A6, and actin. These proteins are part of (actin) or related to (gelsolin, annexin) the cytoskeleton and contractile elements of smooth muscle cells. Analysis of sGC-AF by LC-MS/MS revealed the presence of small amounts of heat shock protein 70 (Hsp70) in the 70 kDa fraction. In view of an earlier report on stimulation of sGC by interaction with this protein [13] , we considered that the observed effects could be caused by Hsp70. Fig. 4A shows a comparison of PCA cytosol (left) and partially purified sGC-AF (right) with respect to total protein stained with Ponceau S (upper panel) as well as Hsp70 and annexin 6 immunostaining (middle and lower panels, respectively). As expected, total 70 kDa protein and annexin A6 were markedly enriched in the course of sGC-AF purification, but Hsp70 was not detectable. These results, which argue against a role of Hsp70, were corroborated by the clear separation of immunoreactive Hsp70 and sGC-AF activity by IEX chromatography (Fig. 4B) .
Studies to elucidate the mechanism underlying the effect of sGC-AF
In view of our recent observation that NO-stimulated sGC looses activity when incubated over prolonged periods of time at 37°C [21] , we assumed that sGC-AF might stabilize the NO-bound enzyme. However, as shown in Fig. 5A , sGC activity under control conditions did not decrease during 2-10 min of incubation, and the effect of sGC-AF remained constant in that time period. As a reduced heme iron center is essential for the NO response of sGC [22] , we tested whether the effect of sGC-AF is related to the redox state of the enzyme. DEA/NO-stimulated cGMP formation was determined in the absence and presence of sGC-AF upon oxidation of sGC with potassium ferricyanide (K 3 [Fe (CN) 6 ]) and reduction by sodium dithionite. To account for treatment effects and confirm enzyme oxidation, the measured rates of cGMP formation were normalized to the values measured in the presence of the heme mimetic cinaciguat (10 µM) with sGC that had been treated with Tween 20 (0.5% (v/v)) to remove enzyme-bound heme [6, 23] . As shown in Fig. 5B , the effect of sGC-AF on DEA/NO-stimulated activity persisted in the presence of sodium dithionite. Oxidized sGC was A. Kollau et al. Biochemical Pharmacology 156 (2018) [168] [169] [170] [171] [172] [173] [174] [175] [176] insensitive to NO, and sGC-AF had no effect. Fig. 5C shows that sGC-AF neither affects the cinaciguat-stimulated cGMP formation under control conditions nor activity of the heme-free enzyme (in the presence of Tween 20) . These data demonstrate that reduced enzyme-bound heme is essential for the effect of sGC-AF, reminiscent of sGC stimulation by YC-1 and the related compound BAY 41-2272. As shown in Fig. 5D , BAY 41-2272 and sGC-AF had virtually identical effects, and a further increase in sGC activity was observed in the combined presence of both agents.
Discussion
Following our initial observation of an unexpected increase in the maximal rates of cGMP formation by NO-stimulated sGC in the presence of cytosolic PCA preparations [15] , we attempted to purify, identify and characterize the responsible protein(s). The purification protocol described in the present study did not result in isolation of a single protein but yielded a protein mixture with major components corresponding to 40, 70, and 100 kDa on SDS-PAGE. LC-MS/MS analysis revealed that the final preparation of sGC-AF contained albumin, actin, annexin A6 and gelsolin. Except for albumin, these proteins are all related to or part of the cytoskeleton and contractile elements of smooth muscle [24] [25] [26] [27] [28] [29] [30] . None of the single proteins mimicked the effect of the partially purified preparations (not shown), indicating that sGC-AF is a protein complex rather than a single protein. In view of attempts to isolate sGC from blood platelets by one of us (B.M.) in the mid 1980s, the apparent modulation of sGC activity by cytoskeletonrelated proteins is an intriguing finding. Platelets and smooth muscle cells share common mechanisms with respect to cGMP signaling and Ca 2+ handling, including high expression levels of the α 1 β 1 sGC heterodimer [31, 32] . In the second half of the 1980s we attempted to purify sGC from bovine platelets using a wide variety of methods, including the protocol applied for the successful purification of the enzyme from bovine lung [33] . However, we failed to obtain a pure enzyme, and the pooled fractions from final purification steps typically contained actin and gelsolin as major contaminating proteins (Mayer, B., Guthmann, F. and Böhme, E. unpublished). This observation was not further pursued and never published, but together with the present findings it might support the view that sGC is modulated by an interaction with contractile elements in smooth muscle cells and platelets. The various isoforms of actin are not only the basic framework of the cytoskeleton in all cells, but also constitute the main part of the thin filaments and, together with myosin (and other proteins), form the contractile apparatus of smooth muscle [24, 25] . Actin is also essentially involved in the shape change of activated platelets [34] . Gelsolin is an actin-binding and -severing protein, which regulates actin filament elongation or depolymerization [26] [27] [28] . Interestingly, the vasodilatorstimulated phosphoprotein (VASP), an established target of cGMP-dependent protein kinase that is associated with the cytoskeleton [35] , was reported to stabilize actin filaments to the severing effect of gelsolin without interfering with gelsolin binding [36] . Annexins are a family of Ca
2+
-and phospholipid-binding proteins [29] . Among these, isoform A6 regulates membrane trafficking and signal transduction. Besides other functions, it appears to serve as an anchoring protein, linking actin filaments to the cell membrane [30] and to interact with small Ca 2+ -binding proteins of the S100 family [37, 38] . These proteins act as sensors for free cytosolic [Ca 2+ ] and are involved in the regulation of a wide variety of cellular processes [39, 40] . In both smooth muscle cells and platelets, the sGC/cGMP pathway counteracts the effects of intracellular free Ca 2+ , resulting in relaxation and inhibition of aggregation, respectively, processes that essentially involve the cytoskeleton. Thus, it is likely that the interaction of sGC with the activating factor described in the present study is modulated by Ca 2+ ions. It is certainly warranted to clarify this issue in future work. Our data indicate that sGC-AF increases maximal rates of cGMP formation by NOsaturated sGC without affecting basal sGC activity. The effect was independent of the NO donor (DEA/NO or GSNO) applied and was similar in magnitude when the enzyme was exposed to 0.3 and 10 µM DEA/NO. Thus, effects on the rate of NO release or NO consumption can be excluded, indicating that sGC-AF converts the NO-bound enzyme into a more active conformation. The increase in activity caused by sGC-AF was similar to that observed with saturating concentrations of the sGC stimulator BAY 41-2272, but their effects are clearly distinguishable.
The pronounced, about 10-fold increase in basal activity caused by BAY 41-2272 [41] was not observed with sGC-AF. Moreover, the effects of the two agents were additive even though BAY 41-2272 was present at a saturating concentration of 10 µM [42] , indicating that their interaction with NO-bound sGC involves distinct mechanisms. BAY 41-2272 supports CO activation of sGC by inducing the formation of a 5-coordinate heme-CO complex [43] , but the physiological mechanism underlying stimulation of sGC by endogenous CO is unknown. Work is in progress in our laboratory to test the intriguing possibility that sGC-AF functions as endogenous sGC stimulator mediating CO activation of the enzyme in smooth muscle.
